| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.79B | +26.4% |
| Cost of Revenue | $1.25B | +26.8% |
| Gross Profit | $1.54B | +26.1% |
| R&D Expense | $382.3M | +17.7% |
| SG&A Expense | $428.8M | +20.2% |
| Operating Income | $728.6M | +35.1% |
| Pre-tax Income | $766.2M | +33.7% |
| Income Tax | $144.7M | +111.9% |
| Net Income | $621.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.10B | +58.9% |
| Short-term Investments | $157.2M | -8.1% |
| Accounts Receivable | $255.6M | +48.2% |
| Inventory | $564.6M | +34.6% |
| Current Assets | $2.18B | +39.5% |
| Total Assets | $4.19B | +16.0% |
| Current Liabilities | $369.4M | +25.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $838.2M | +6.3% |
| Capital Expenditures | $172.0M | +17.7% |
| Investing Cash Flow | -$157.3M | -170.5% |
| Financing Cash Flow | -$285.9M | +67.2% |
| Free Cash Flow | $666.2M | +3.7% |
| -65.2% |
| EPS (Basic) | $12.94 | -64.8% |
| EPS (Diluted) | $12.86 | -64.9% |
| Total Liabilities |
| $662.7M |
| +40.6% |
| Stockholders' Equity | $3.53B | +12.3% |